Sort
39,280 grants matching “leukemia”
Optimal Predictors of Response to Trastuzumab
$584,668David L Rimm · Yale University · R01 · FY2010 · CA
Gut L-Histidine Metabolism and Histamine Signaling in Colonic Neoplasia
$584,586James Versalovic · Baylor College Of Medicine · U01 · FY2015 · CA
Defining the Role of Alternative Polyadenylation in Macrophage Differentiation and Function
$584,541Claire L Moore · Tufts University Boston · R01 · FY2021 · AI
Defining the Role of Alternative Polyadenylation in Macrophage Differentiation and Function
$584,541Claire L Moore · Tufts University Boston · R01 · FY2024 · AI
Defining the Role of Alternative Polyadenylation in Macrophage Differentiation and Function
$584,541Claire L Moore · Tufts University Boston · R01 · FY2022 · AI
Defining the Role of Alternative Polyadenylation in Macrophage Differentiation and Function
$584,541Claire L Moore · Tufts University Boston · R01 · FY2023 · AI
Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care
$584,528Cynthia Ann Toth · Duke University · R01 · FY2025 · EY
Molecular Epidemiology of NHL and CLL
$584,461James R Cerhan · Mayo Clinic Rochester · R01 · FY2011 · CA
Predicting clinical outcome in individuals with small CLL B cell clones
$584,454Neil E Kay · Mayo Clinic Rochester · R01 · FY2019 · CA
Biological determinants of colorectal cancer outcomes in Latinos of diverseýancestral origins
$584,261Stephanie L. Schmit · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · CA
Structure, Function and Applications of Inteins
$584,219Tom W Muir · Princeton University · R01 · FY2023 · GM
Structure, Function and Applications of Inteins
$584,219Tom W Muir · Princeton University · R01 · FY2024 · GM
Structure, Function and Applications of Inteins
$584,219Tom W Muir · Princeton University · R01 · FY2025 · GM
Neurodevelopmental Effects of Cannabis and its Epigenetic Regulation
$584,165Yasmin L Hurd · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · DA
Alternative RNA splicing and protein products in leukemia outcome (PQ11)
$584,002Scott A. Ness · University Of New Mexico Health Scis Ctr · R01 · FY2015 · CA
COMBINING A NOVEL PAN-RAF INHIBITOR WITH MEK INHIBITION IN PEDIATRIC, ADOLESCENT, AND YOUNG ADULT ACUTE MYELOID LEUKEMIA (AML)
$584,001Regents Of The University Of California, San Francisco, The · · FY2022 · Defense Health Agency
Discovery of Somatic Noncoding Variants that Serve as Drivers in Pediatric Cancers
$583,990Jinghui Zhang · St. Jude Children'S Research Hospital · R01 · FY2018 · CA
Machine learning with immunogenetics for the prediction of hematopoietic cell transplant outcomes
$583,984Katharine C Hsu · Sloan-Kettering Inst Can Research · R01 · FY2024 · HL
Parental genotypes and exposures in sporadic retinoblastoma
$583,922Arupa Ganguly · University Of Pennsylvania · R01 · FY2009 · CA
Single-Cell Methods for Analysis of Clonal Heterogeneity and Evolution in Cancer
$583,874Jerald P Radich · Fred Hutchinson Cancer Research Center · R01 · FY2015 · CA
Development of A HTLV-1 Vaccine
$583,747Glen N. Barber · University Of Miami School Of Medicine · R01 · FY2023 · CA
Quantitative Volume and Density Response Assessment: Sarcoma and HCC as a Model
$583,741Lawrence H Schwartz · Columbia University Health Sciences · U01 · FY2012 · CA
Phenotypic variability within isogenic population of lymphocytes
$583,708Gregoire Bonnet · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
A high-throughput platform to identify selective allosteric inhibitors of the PLC-y isozymes
$583,609Qisheng Zhang · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA
Mechanisms of treatment failure in chimeric antigen receptor T cell therapy
$583,532Brian Till · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA